GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RAPT Therapeutics Inc (FRA:0RA) » Definitions » Net Interest Income (for Banks)

RAPT Therapeutics (FRA:0RA) Net Interest Income (for Banks)


View and export this data going back to 2019. Start your Free Trial

What is RAPT Therapeutics Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


RAPT Therapeutics Business Description

Industry
Traded in Other Exchanges
Address
561 Eccles Avenue, South San Francisco, CA, USA, 94080
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.